Hans L.
- Country
- Norway
- Department
- Lovisenberg Diakonale Sykehus, Medisinsk avdeling
Research Overview
Data & Insights
Has run more than one trial at 0 of 27 partner sites.
Specializations
Hepatology Focus
The investigator specializes in studying non-alcoholic steatohepatitis (NASH) and its progression from non-alcoholic fatty liver disease (NAFLD), with particular attention to patients with fibrosis in non-cirrhotic stages.
- Liver Disease Progression
- Hepatic Steatosis Assessment
- Fibrosis Management
Primary research interest includes evaluation of novel therapeutic approaches for liver inflammation and hepatocyte ballooning.
Metabolic Disorders
Focuses on the interconnection between metabolic risk factors and liver disease, particularly examining conditions associated with NASH including obesity, type 2 diabetes mellitus, and dyslipidemia.
- Insulin Resistance
- Adipose Tissue Dysfunction
- Hepatic Lipogenesis
Investigates the role of hyperinsulinemic states in liver disease development.
Therapeutic Development
Conducts research on pharmacodynamic properties of innovative compounds for treating non-cirrhotic NASH with fibrosis, focusing on safety and tolerability assessments.
- Drug Safety Evaluation
- Therapeutic Response
- Clinical Efficacy
Specializes in early-phase clinical investigations of novel therapeutic agents.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.